180 related articles for article (PubMed ID: 25321172)
1. Nanomedicine strategies for targeting skin inflammation.
Abdel-Mottaleb MM; Try C; Pellequer Y; Lamprecht A
Nanomedicine (Lond); 2014 Aug; 9(11):1727-43. PubMed ID: 25321172
[TBL] [Abstract][Full Text] [Related]
2. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
3. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
5. Tailored dendritic core-multishell nanocarriers for efficient dermal drug delivery: A systematic top-down approach from synthesis to preclinical testing.
Hönzke S; Gerecke C; Elpelt A; Zhang N; Unbehauen M; Kral V; Fleige E; Paulus F; Haag R; Schäfer-Korting M; Kleuser B; Hedtrich S
J Control Release; 2016 Nov; 242():50-63. PubMed ID: 27349353
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
7. Size dependent skin penetration of nanoparticles in murine and porcine dermatitis models.
Try C; Moulari B; Béduneau A; Fantini O; Pin D; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2016 Mar; 100():101-8. PubMed ID: 26792104
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M; Mehnert W; Korting HC
Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
[TBL] [Abstract][Full Text] [Related]
9. Current view on nanosized solid lipid carriers for drug delivery to the skin.
Kristl J; Teskac K; Grabnar PA
J Biomed Nanotechnol; 2010 Oct; 6(5):529-42. PubMed ID: 21329046
[TBL] [Abstract][Full Text] [Related]
10. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin.
Jensen LB; Petersson K; Nielsen HM
Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463
[TBL] [Abstract][Full Text] [Related]
11. Emerging applications of nanomedicine in dermatology.
Saraceno R; Chiricozzi A; Gabellini M; Chimenti S
Skin Res Technol; 2013 Feb; 19(1):e13-9. PubMed ID: 22175818
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges?
Vogt A; Wischke C; Neffe AT; Ma N; Alexiev U; Lendlein A
J Control Release; 2016 Nov; 242():3-15. PubMed ID: 27449743
[TBL] [Abstract][Full Text] [Related]
14. Quercetin topical application, from conventional dosage forms to nanodosage forms.
Hatahet T; Morille M; Hommoss A; Devoisselle JM; Müller RH; Bégu S
Eur J Pharm Biopharm; 2016 Nov; 108():41-53. PubMed ID: 27565033
[TBL] [Abstract][Full Text] [Related]
15. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles enhance therapeutic outcome in inflamed skin therapy.
Abdel-Mottaleb MM; Moulari B; Beduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Sep; 82(1):151-7. PubMed ID: 22728016
[TBL] [Abstract][Full Text] [Related]
17. Strategy of topical vaccination with nanoparticles.
Jung S; Patzelt A; Otberg N; Thiede G; Sterry W; Lademann J
J Biomed Opt; 2009; 14(2):021001. PubMed ID: 19405714
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.
Zhang Z; Tsai PC; Ramezanli T; Michniak-Kohn BB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(3):205-18. PubMed ID: 23386536
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
